📰 Lilly Bio News
Lilly Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lilly Bio. Real-time updates on events, politics, business and more.
January 18, 2024
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce the appointment of pharma...
January 8, 2024
BOSTON, Jan. 8, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the formation of its new Biopharma Advisory
December 14, 2023
CAMBRIDGE, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the appointment of Christi
October 5, 2023
Succeeding Mike Mason on January 1, 2024 will be company veteran Patrik Jonsson, who currently serves as EVP and president of Lilly USA.
October 4, 2023
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced changes to its executive leadership team. Mike Mason, executive vice president and president...
June 30, 2023
Discover the career paths of 11 of the highest-paid healthcare CEOs, from Albert Bourla of Pfizer to Kevin Lobo of Stryker. Learn about their education, experie
April 19, 2023
Alfasi Group boss Avri Alfasi and wife Michal have sold their Toorak compound for $34m, while golfer Adam Scott lists vacant Rockhampton block for $10m.
August 29, 2022
A fireside chat between Purdue University President Mitch Daniels and David Ricks, chair and CEO of Eli Lilly and Company, will be the highlight of the seventh annual Lilly Day at Purdue on Wednesday (Aug. 31).
December 7, 2021
/PRNewswire/ -- Globant (NYSE: GLOB), a digitally native company focused on reinventing business through innovative technology solutions, announced today the...
December 7, 2021
/PRNewswire/ -- Globant (NYSE: GLOB), a digitally native company focused on reinventing business through innovative technology solutions, announced today the...